CABOMETYX, Cabozantinib, Exelixis, FDA, HCC, hepatocellular carcinoma, Sorafenib, USFDA
Cabozantinib is FDA-approved for hepatocellular carcinoma
On January 14, 2019, cabozantinib (CABOMETYX, Exelixis, Inc.) was approved by the Food and Drug Administration for patients with hepatocellular carcinoma (HCC) who have previously been treated with sorafenib. The appr..
What are the targeted drugs for lymphoma?
LymphomaThe lymph in the human body is actually complicated. Lymphoma is the fastest and the highest death in malignant tumors, because the lymphatic system of the human body has a great effect on the whole body. Once cancer cells..
Anti cancer drugs approved between 2005 to 2014
Approved drugs by ASCO from 2005 to 2014Since ASCO published its first clinical cancer progress report in 2005, it has witnessed solid and determined progress in the field of oncology in the past 10 years.In the past 10 years, mor..
Liver, Treatment
A new drug in the treatment of liver cancer
A research team at the Cancer Research Institute (CSI) of the National University of Singapore has developed a novel peptide drug called FFW that may prevent the development of hepatocellular carcinoma (HCC) or primary liver ca..
Disease, Liver, Thrombocytopenia
Drug for thrombocytopenia
Dova Pharmaceuticals said that the US Food and Drug Administration (FDA) approved its subsidiary AkaRx's new drug Doptelet (avatrombopag) tablets for treating low platelet counts (thrombocytopenia) in adults with chronic liver dis..
Latest anticancer drugs in the market
Here's the list of latest anticancer drugs in the market. 1) Epacadostat Epacadostat is undoubtedly a bright star in the IDO field. The results of clinical trials show that the combination of IDO inhibitors and progra..
A drug used for alcoholism can treat cancer by targeting macrophages
A research group led by Yuya Terashima from Tokyo University found that a drug used for alcoholism can treat cancer by targeting macrophages. As per WHO and International Agency for Research on Cancer (IARC) data, there were 18..
Drugs, Immunotherapy
New immunotherapy drug in cancer
Immune checkpoint inhibitors are a class of drugs that fight with the immune system of the body to fight cancerous cells. However, most patients do not respond to these therapies. There is a newer class of drug that targets two pr..
Acalabrutunib, Avelumab, CART therapy, Dabrafanib, Kymriah, Latest drugs, Midostaurin, Niraparib, Pembrolizumab, Tecartus, Tisagenlecleucel, Trametinib, USFDA
Latest drugs in the treatment of cancer
July 2021: Check out the latest drugs in the treatment of cancer. Every year, after examining the trials and other important factors, the USFDA approves drugs, and thus cancer patients can now believe that a cure is very near. ..